Research

REVEAL Study

Research Detail

Sponsor

Astellas Pharma Global Development, Inc.

Category

Age-Related Macular Degeneration

Location

Greenfield, WI

Enrollment

Description

A Non-interventional, observational study to evaluate treatment patterns and safety of Avacincaptad Pegol (ACP/IZERVAY™) in routine clinical practice in patients with geographic atrophy secondary to Age-Related Macular Degeneration.

Research Goals

To better understand patient experiences, treatment, management and safety of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) when treated with IZERVAY ™ eye injections.

Sponsor